Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

No trades yesterday now up 20% on low volume.

SP up 20% on very little trade. All I can think of is looking back at the results there are several mentions re different parts of the world taking up full implementation of the Cardio by the end of this year. OK I appreciate we have a long way to go to 2010, but as full implementation will only occur by gradual progression, are we in for a good news release.
Those director trades a few days ago, nicely out of the way.
After no trades yesterday, something must be stirring.
I did think of buying a few more first thing this morning, but missed it. Win some loose some.

In Gordon Browns budget, Alistair Darling stated that the NHS budget would not be cut. Treasury figures released yesterday, show a cut from 104.6 billion to 102.3 billion (Lied again).
The point of posting is that he stated that no cuts would be made in front line services (if we can believe him).
Either way, I think Deltex could/should gain.
'No cuts' in front line services, conclusion obvious.
'Cuts' in front line services will mean that areas of cost savings need to be looked at, hence the CardioQ.
All this needs is common sense to prevail. Mind you that is a lot to ask from those purse string, pen pushing, moronic bureaucrats that manage (sic) our NHS.

Always nice to see directors electing to take shares in lieu of cash, for remuneration. Advisers also feel it's a better option. With 100 million shares in issue another half mil, won't make much difference. At this stage in Deltex's progress the cash saved albeit not much will still no doubt help their bank balance.

Ops double counting again (see Georges post). Perhaps I should go into politics.

greekman, I am as keen as you are to see DEMG's sp rise but you cannot count todays deals twice, they are the same deal.
2517

George,

You say....you cannot count todays deals twice (nice if you could).

Thanks for that, had a grey moment (got carried away a bit). I was mislead by MoneyAm releases. They released the initial shares granted announcement then several hours later released a separate announcement for each director. But I should have noticed the amounts per director were the same. Will edit post 628.
Thanks for pointing it out.

Still a waiting game with DEMG, but I am convinced they will come good over the next 18 - 24 months.
2517

Could this be a major sign of expected contracts, new or increased.
This is the third time in 4 months board members have either purchased shares or/and took shares in lieu of fees.
Whilst I appreciate this dilutes the value of our holdings, I feel the money saved by the company is a big positive.
You don't take such a deal unless you have a massive belief that you will benefit.
I know directors do not always call it right but when they all jump in together it must be a sign of positive vibrations filtering through.
As most know from my previous posts, my share portfolio have a very heavy percentage of Deltex shares. Even so I did increase my holdings a few months ago.
Whilst now even more positive, my own holdings in this company are again a HOLD.
Wary re all eggs in same basket syndrome.

non-execs at DEMG do the same every year, so I read zilch all into it
DEMG always looks good, but progress is mind-numbingly slow.

Notlob,

Just checked that myself. Although it is correct that the same happened over the last couple of years, it does appear they are now all doing the same, and to a bigger extent.
But I do take your point.

Also nice to see another Deltex poster on here.

greekman

don't want to appear pedantic on this one, but last year they issued approx 370K shares to non-execs, this year it is exactly the same, so I don't see any trend at all.

I think doing this is a good idea, and I believe that DEMG will return shareholder value at some point. My feeling is they will get taken out by a larger company, as DEMG don't seem to have the resources to really push this out, although I give them full marks for trying. It seems an uphill battle and because they are starting from such a low base, with regular doses of new equity, giving shareholders a return has , so far, proved impossible.

Notlob,

OK, I see that the shares issued are the same.
No problem re 'pedantic'. I would sooner someone politely as you have, point out an error than allow it to continue (must keep more accurate records, I missed a 0 off last year, perhaps there is a job for me if Alistair Darling moves over).
Still as you say it is a good idea. Perhaps the time to really take note is when they do not take this route but instead go for the monetary award option.

Like you I can see a larger company taking them out if/when things really get moving as that for most companies appears to be the way of things.

just be better if we were sitting at 20p+, then any take-out who porbably have to be pitched 30p+

Current sp does leave DEMG open to a bid of 15p or 16p or so.

DEMG would have done all the hard ground-work, only for another set of shareholders to benefit!

DEMG does not seem to have taken part in the recent small cap rally, least not to the same extent that others in my portfolio have, which is, I must admit, a trifle concerning. Lets hope it plays catch up soon.

Should be a trading statement due in about 4 weeks time.
2517

It is obvious now that NHS funding in true terms is to be cut. According to the weekend media, plans are already being drawn up to see where vast swathes of cash can be saved over the next few years. Efficiency in all areas are to be targeted ( I hope that top of the list is management). I know we have all said this before but as we all know, the Cardio system can due to shorted hospital stays, lower re-admission levels save money as well as lives.
No just hope that this money saving exercise won't result in the setting up of even more high cost quangos being set up, which appears to be the usual way to go by the government.
I do feel though that the present situation in the NHS is unsustainable and that this time commonsense will prevail. With the public mood as it is, I can't see it any other way, no matter which party is running (is anyone) the country.

With a steady downturn in the sp over the last 3 weeks we need a good Trading Statement, with some definite sign of new contracts and/or increased sales to existing customers.

If we do not see some sign of such, more and more investors will ditch their investments and start looking for somewhere else to put their money.

It's no good having a good product if insufficient customers want it.

Still a fan of Deltex, but patience wearing a bit thin.

Yes I totally agree greekman, we seem to have been in DEMG forever and hopefully the month on month of increased sales (and therefore revenue) will have continued to date. Although it is money tied up, I am not looking to sell yet, the patience of Jobe is required here. The NHS does nothing in a hurry, even when it means saving money, time and lives, so we shall be in the waiting room for a bit longer yet.
2517

Surprised to see the Trading Statement his AM, it's a bit earlier than expected. It is the usual 'We are making progress report we have come to expect'.
As previously said, it is no good having an excellent product if you can't sell it, 'in sufficient quantities'.
The statement,'The Company expects sales for the six months ended 30 June 2009 to be approximately 2.6 million which is 5% higher than in the first half of 2008', is in my opinion, disappointing.
For a well established company, a 5% increase would be very acceptable, but for a company in Deltex's market position, they need to find a far bigger push than this.

The statement, 'Sales were held back in Spain following delays in setting up a major government-led assessment of CardioQ-ODM, with a projected sales value to the Company in excess of 250,000, and deferral of a large international order', still could bode well, but orders like these MUST start coming through soon or Deltex will loose many more investors including myself.
But for the time being, I will stick with it, at least to see if we end 2009 in a better position than we are now, and that mentioned 'international order', comes through.

5% sales growth is pretty awful, imo, for a company in DEMG's position.
It simply is nowhere near good enough, best thing would be if a larger group with the right resources to push CardioQ out took them over.

If this was a patients chart, it would look like they were loosing blood pressure and possibly bleeding to death.
If Deltex do not get some more orders soon, they might be joining the patient.
Not de-ramping this share as its the biggest holding in my share portfolio, just trying to face facts, as becoming more disillusioned by the day.
I am comparing them with another of my holdings that wandered along a lonely road at snail pace (PTI). They had a fairly good portfolio of drugs, but needed a company with more clout to push things along. BTG took over and since then momentum has increased at a far greater pace. Perhaps it really is time for Deltex to succumb to one of the bigger players, something I has said many times I did not want to happen.